Mechanisms of myocardial protection by amino acids: Facts and hypotheses

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 8, 1996, Pages 627-633

  Pisarenko, Oleg I ^a  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

Free radical scavenging; Intracellular metabolism; Ion homeostasis; Ischaemia reperfusion injury; Membrane integrity

Indexed keywords

AMINO ACID; ASPARTIC ACID; BRANCHED CHAIN AMINO ACID; CYSTEINE; GLUTAMIC ACID; HISTIDINE; METHIONINE; OXYGEN RADICAL; TAURINE;

CALCIUM TRANSPORT; ENERGY METABOLISM; HEART PROTECTION; HEART RATE; HUMAN; INOTROPISM; MITOCHONDRION; NONHUMAN; REVIEW; SARCOLEMMA; SARCOPLASMIC RETICULUM;

EID: 0029811517     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb01748.x     Document Type: Review

References (87)

1. Opie LH. The Heart. Physiology, Metabolism, Pharmacology and Therapy. Gruine & Stratton Ltd, London. 1984.
2. Bender DA. Amino Acid Metabolism. John Wiley & Sons, New York. 1978.
3. Katz AM. Physiology of the Heart. Raven Press, New York. 1977.
4. Franconi F, Martini F, Stendardi I, Matucci R, Ziletti L, Giotti A. Effect of taurine on calcium level and contractility in guinea-pig ventricular strips. Biochem. Pharmacol. 1982; 31: 3181-6.
5. Read W, Welty J. Effect of taurine on epinephrine- and digoxininduced irregularities of dog heart. J. Pharmacol. Exp. Ther. 1963; 139:283-9.
6. Kramer J, Chovan J, Schapper S. The effects of taurine on calcium paradox and ischémie heart failure. Am. J. Physiol. 1981; 240:H238-46.
7. Azari J, Huxtable R. The mechanism of the adrenergic stimulation of taurine influx in the heart. Eur. J. Pharmacol. 1980; 61:217-23.
8. Azuma J, Hasegawa H, Sawamura A. Therapy of congestive heart failure with orally administered taurine. Clin. Ther. 1983; 5: 398-408. . :
9. Kulakowski E, Maturo J, Schaffer SW. The identification of taurine receptors from rat heart sarcolemma. Biochem. Biophys. Res. Commun. 1978; 80: 936-41.
10. + responses induced by isoproterenol and methylxanthines in isolated perfused guineapig hearts exposed to elevated K. J. Mol. Cell. Cordial. 1975; 7: 249-73.
11. Sawamura A, Azuma J, Harada H et al. Protection by oral treatment with taurine against the negative inotropic effects of lowcalcium medium on isolated perfused chick heart. Cardiovasc. Res. 1983; 17: 620-6.
12. Akera T, Ku D, Brody TM. Alterations of ion movements as a mechanism of drug-induced arrhythmias and inotropic responses. ' In: Huxtable R, Barbeau A (eds). Taurine. Raven Press, New York. 1976; pp. 121-34.
13. Welty JD, Welty MC. Effects of taurine in subcellular calcium dynamics in the normal and cardiomyopathic hamster heart. In: Schaffer SW, Baskin SI, Kocsis JJ (eds). The Effects of Taurine on Exitable Tissues. Spectrum Publishing, New York. 1981; pp. 295-312.
14. Sebring LA, Huxtable RJ. Taurine modulation of calcium binding to cardiac sarcolemma. J. Pharmacol. Exp. Ther. 1985; 232: 445-51.
15. Huxtable RJ, Sebring LA. Towards an unifying theory for the action of taurine. Trends Pharmacol Sci. 1986; 7:481-5.
16. Chovan J, Kulakowski E, Benson B, Schapper S. Taurine enhancement of calcium binding to rat heart sarcolemma. Biochim. Biophys. Acta 1979; 551: 129-36.
17. Thurston JH, Hauhart RE, Naccarato EF. Taurine: Possible role in osmotic regulation of mammalian heart. Science 1981; 214: 1373-4.
18. Huxtable RJ, Chubb J. Adrenergic stimulation of taurine transport by the heart. Science 1977; 198: 409-11.
19. Crass MF, Lombardini JB. Release of taurine from the oxygendeficient perfused heart. Proc. Soc. Exp. Biol. Med. 1978; 157: 486-8.
20. Lombardini JB. Effect of isoproterenol and metoxamine on the contents of taurine in rat tissues. J. Pharmacol. Exp. Ther. 1980; 213: 399-405.
21. Chapman RA, Suleiman MS, Rodrigo GS. Intracellular taurine, intracellular sodium and defense against cellular damage. In: Harm YE, Noble D (eds). Cardiac Ion Channels and Effects of Taurine on the Heart. Kluwer Academic Publishers, Boston. 1993; pp. 73-92.
22. Earm YE, Ho WK, So IS, Leem CH, Han J. Effect of taurine on the activation of background current in cardiac myocytes. In: Earm YE, Noble D (eds). Cardiac Ion Channels and Effects of Taurine on the Heart, Kluwer Academic Publishers, Boston. 1993; ppr 132-40.
23. Iwata H, Fujimoto S. Potentiation by taurine of the inotropic effect of ouabain and the content of intracellular calcium and taurine in the heart. Experienlia 1976; 31: 1559-61.
24. Schaffer SW. Review: Myocardial physiological effects of taurine and their significance, Adv. Exp. Med. Biol. 1992; 315: 105-20.
25. Pasantes-Morales H, Wright CE, Gaull GE. Taurine protects lymphoblastoid cells from iron-ascorbate induced damage. Biochem. Pharmacol. 1985; 34: 2205-7.
26. Wright CE, Lin TT, Syurman JA, Gaul GE. Taurine scavenges oxidized chlorine in biological systems. In: Oja SS (ed.). Biological Actions and Clinical Perspectives. Alan R. Liss Inc., New York. 1985; pp. 137-47.
27. Ohta H, Azuma J, Awata N et al, Mechanism of the protective action of taurine against isoprenaline induced myocardial damage. Cardiovasc. Res, 1988; 22:407-13.
28. Milei J, Ferreira R, Llesuy S, Forcada P, Covarrubias J, Boveris A. Reduction of reperfusion injury with preoperativc rapid intravenous infusion of taurine during myocardial revascularization. Am. Heart J. 1992; 123: 339-45.
29. Rau EE, Shine KI, Gervais A, Douglas AM, Amos EC. Enhanced mechanical recovery of anoxic and ischémie myocardium by amino acid reperfusion. Am. J. Physiol. 1979; 23é: H4873-9.
30. Rosenkranz ER, Okamoto F, Buckberg GD, Robertson CM, Vtnter-Johansen J, Buggyi H. Safety of prolonged aortic clamping with blood cardioplegia. III. Aspartate enrichment of glutamateblood cardioplegia in energy-depleted hearts after ischémie and reperfusion injury. J. Thorac. Cardiovasc Surg. 1986; 91: 428-35.
31. Bittl J, Shine KI. Protection of ischémie rabbit myocardium by glutamic acid. Am. J. Physiol. 1983; 245: H406-12.
32. Taegtmeyer H. Metabolic response to cardiac hypoxia. Increased production of succinate by rabbit papillary muscle. Circ. Res. 1978; 43: 808-15.
33. Haas DW. Phosphorylation coupled to the oxidation of NADH by fumarate in digitonin fragments of beef heart mitochondria. Biochim. Biophys. Ada. 1964; 92:433-9.
34. Pisarenko OI, Khlopkov VN, Ruuge EK. A 'H-NMR study of succinate synthesis from exogenous precursors in oxygen-deprived rat heart mitochondria. Kochern. Int. 1986; 12:145-53.
35. Sanborn T, Gavin W, Berkowitz S, Perille T, Lesch M. Augmented conversion of aspartate and glutamate to succinate during anoxia in rabbit heart. Am. J. Physiol. 1979; 273: H535-41.
36. Wiesner RJ, Deussed A, Borst M, Schrader J, Grieshaber MK. Glutamate degradation in the ischémie dog heart: Contribution to anaerobic energy production. J. Mot. Cell. Cardiol. 1989; 21: 49-59.
37. Taegtmeyer H, Rüssel RR. Glutamate metabolism in rabbit heart: Augmentation by ischemia and inhibition with acetoacetate. J. Appl. Cardiol. 1987; 2: 231-49.
38. Wright G. Amino acids in the treatment of ischaemic heart disease. J. Mol. Cell. Cardiol. 1985; 17:441-3.
39. Owen TG, Hochachka PW. Purification and properties of dolphin muscle aspartatc and alanine transaminases and thcir possible roles in the energy metabolism of diving mammals. Kochern. J. 1974; 143: 541-53.
40. Hohl Ch, Oestreich R, Rosen P, Wiesner R, Grieshaber M. Evidence for succinate production by reduction of fumarate during hypoxia in isolated adult rat heart cells. Arch. Kochern. Biophys. 1987; 259: 527-35.
41. Pisarenko OI, Studneva IM, Shulzhenko VS, Korchazhkina OV, Kapelko VI. Substrate accessibility to cytosolic aspartate aminotransferase improves posthypoxic recovery of isolated rat heart. Biochem. Mol. Med. 1995; 55: 138-48.
42. Snaith ChD, Wright G, Lofkin M. The effects of aspartate and 2-oxoglutarate upon glycolytic energy metabolites and mechanical recovery following global ischaemia in isolated rat heart. J. Mol. Cell. Cardiol 1992; 24: 305-15.
43. Choong YS, Gavin JB, Armiger LC. Effects of glutamic acid on cardiac function and energy metabolism of rat heart during ischemia and reperfusion, J. Mol. Cell. Cardiol. 1988; 20:1043-51.
44. Pisarenko OI, Studneva IM, Khlopkov VN. Metabolism of the tricarboxyh'c acid cycle intermediates and related amino acids in ischémie guinea pig heart. Biomed. Biochim. Ada. 1987; 46: 141-5.
45. Digerness SB, Reddy WJ. The malate-aspartate shuttle in heart mitochondria. J. Mol. Cell. Cardiol. 1976; 8: 779-85.
46. Kondrashova MN, Maevsky El, Babayan GB, Saakyan R, Akhmerov RN. Adaptation to hypoxia by turning metabolism to succinate utilization. In: Severin SE (éd.). Mitochondria: Biochemistry and Ultrastucture. Science, Moscow. 1973; pp. 112-29.
47. Whereat AF, Hull FE, Orishimo MW, Rabinowitz JL. The role of succinate in the regulation of fatty acid synthesis by heart mitochondria. J. Biol. Chem. 1967; 242:4013-22.
48. Hochachka PW, Neely JR, Griedzic WR. Integration of lipid utilization with Krebs' cycle activity in muscle. Fed. Am. Soc. Exp. Biol. 1977; 36: 2009-14.
49. Pisarenko O, Studneva I, Khlopkov V, Solomatina E, Ruuge E. An assessment of anaerobic metabolism during ischemia and reperfusion in isolated guinea pig heart. Biochim. Biophys. Ada. 1988; 934: 55-63.
50. Katunuma N, Okada M, Nishii Y. Regulation of the urea cycle and TCA cycle by ammonia. Adv. Enzyme Regul 1966; 4:317-36.
51. Humphrey SM, Holliss DG, Seelye RN. Adenine pool catabolism in the ischémie, the calcium-depleted and substrate-free anoxic isolated rat heart: Relationship to contracture development. J. Mol. Cell Cardiol. 1984; 16: 1127-36.
52. Shertzer H, Cascarano J. Anaerobic rat heart: Mitochondrial role in calcium uptake and contractility. J. Exp. ZooJ. 1979; 207: 337-50.
53. Haas GS, DeBoer LWV, O'Keefe DD et al. Reduction of post ischémie myocardial dysfunction by substrate repletion during reperfusion. Circulation 1984; 70 (Suppl. 1): 65-74.
54. Rousou JA, Engelman RM, Anisimowicz L et al. Metabolic enhancement of myocardial preservation during cardioplegic arrest. J. Thorac. Cardiovasc. Surg. 1986; 91: 270-6.
55. Thomassen A, Nielsen TT, Bagger JP, Pedersen AK, Henningsen P. Antiischemic and metabolic effects of glutamate during pacing in patients with stable angina pectoris secondary to either coronary artery disease or syndrome X. Am. J. Cardiol. 1991; 68: 291-5.
56. Beyersdotf F, Kirsh M, Buckberg GD, Alien BS. Warm glutamate/aspartate-enriched blood cardioplegic solution for perioperative sudden death. J. Thorac. Cardiovasc. Surg. 1992; 104: 1141-7.
57. Schwalb H, Izhar U, Yaroslavsky E, Borman JB, Uretzky G. The effect of amino acids on the ischémie heart. J. Thorac. Cardiovasc. Surg. 1989;98:551-6.
58. Schwartz RG, Barret EJ, Francis CK, Jacob R, Zaret BL. Regulation of myocardial amino acid balance in conscious dog. J. Clin. Invest. 1985;75:1204-11.
59. McMillin JB. Branched chain amino acid perfusion. J. Thorac. Cardiovasc. Surg. 1989; 98: 632-8.
60. Svedjeholm R, Svensson S, Ekroth R. Trauma metabolism and the heart: Studies of heart and leg amino acid fluxes after cardiac surgery. Thorac. Cardiovasc. Surg. 1990; 38: 1-5.
61. Lovenberg W, Yomori Y. Nutritional factors and cardiovascular disease. Clin. Exp. Hyperten. 1984; A6:417-26.
62. Ganguly PK, Rice KV, Panagia V, Dhalla NS. Sarcolemmal phosphatidylethanolamine AT-methylation in diabetic cardiomyopathy. Ore. Res. 1984; 55: 504-12.
63. Panagia V, Gupta MP, Ganguly PK, Dhalla NS. Methionineinduced positive inotropic effect in rat heart. Ore. Res. 1988; 62: 51-5.
64. Panagia V, Okumura K, Makino N, Dhalla NS. Stimulation of CaJ-pump in heart sarcolemma by phosphatidylethanolamine Nmethylation. Biochim. Biophys. Acta. 1986; 856: 383-7.
65. Limas CJ. Effect of phospholipid mcthylation on /3-adrenergic receptor in the normal and hypertrophied rat myocardium. Ore. Res. 1980; 47: 536-41.
66. Levi WS, Katz RJ, Ruffalo RL, Leiboff RH, Wasserman AG. Potentiation of the hemodynamic effects of acutely administered nitroglycerin by methionine. Circulation 1988; 78: 640-5.
67. Ignarro LJ, Lippton H, Edwards JC el al. Mechanisms of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharmacol. Exp. Ther. 1981; 218: 739-45.
68. Murphy-Chutorian DR, Wexman MP, Grieco AJ et al. Methionine intolerance: A possible risk of factor for coronary artery disease. J. Am. Coll. Cardiol. 1985; 6: 725-31.
69. Blasig IE. Effects of troxerutin and methionine on spin trapping of free oxy-radicals. Biomed. Biochim. Acta 1988; 47: 252-5.
70. Chambers DJ, Astras G, Takahashi A, Manning AS, Braimbridge MV, Hearse DJ. Free radicals and cardioplegia: Organic antioxidants as additives to the St Thomas' Hospital cardioplegic solution. Cardiovasc. Res. 1989; 23: 351-8.
71. Halliwell B. Free radicals, oxygen toxicity and ageing. In: Sohal RS (ed.). Age Pigments. Elsevier/North Holland Boimedical Press, Amsterdam. 1981; pp. 1-62.
72. Suzuki S, Kaneko M, Chapman DC, Dhalla NS. Alterations in cardiac contractile proteins due to oxygen free radicals. Biochim. Biophys. Acta. 1991; 1074: 95-100.
73. Laustiola K, Vuorinen P, Vapaatalo H, Metsa-Ketela T. Effects of cysteine and nitroglycerin on bovine heart guanylate cyclase and on tissue cyclic GMP and lactate of rat atria. Eur. J. Pharmacol. 1983;91:301-4.
74. Andrcoli SP. Captopril scavenges hydrogen peroxide and reduces, but does not eliminate, oxidant-induced cell injury. Am. J. Physiol. 1993; 264: F120-7.
75. Lissi EA, Faure M, Clavero N. Effect of additives on the inactivation of lysozymc mediated by free radicals produced in the thermolysis of 2,2'-azo-bis- (2-aminopropane). Free Rad. Res. Commun. 1991; 14: 373-84.
76. Nath KA, Salahudeen AK. Autoxidation of cysteine generates hydrogen peroxide: Cytotoxicity and attenuation by pyruvate. Am. J. Physiol. 1993; 264: F306-14.
77. 2+, and function in reperfused rat hearts. Am. J. Physiol. 1990; 259: H137-43.
78. Viel P, Fuchs J, Zimmer G. Uncoupler- and hypoxia-induced damage in the working rat heart and its treatment. I. Observation with uncouplers of oxidative phosphorylation. Basic Res. Cardiol. 1985; 80: 107-15.
79. Kukreja RC, Loesser KE, Kearns AA, Naseem SA, Hess ML. Protective effects of histidine during ischemia-reperfusion in isolated perfused rat hearts. Am. J. Physiol. 1993; 264: H1370-81.
80. Todoki K, Okabe E, Kiyose T, Sekishita T, Ito H. Oxygen free radical-mediated selective endothelial dysfunction in isolated coronary artery. Am. J. Physiol. 1992; 262: H806-12.
81. Kusama Y, Bernier M, Hearse DJ. Photoactivation of porphyrins: Studies of reactive oxygen intermediates and arrhythmogenesis in the aerobic rat heart. Cardiovasc. Res. 1990; 24: 676-82.
82. 2+-ATPase of cardiac sarcoplasmic reticulum. Circ. Res. 1991; 69: 1003-14.
83. Misra BR, Misra HP. Vasoactive intestinal peptide, a singlet oxygen quencher. J. Biol. Chem. 1990; 265: 15371-4.
84. Zs-Nagy I, Floyd RA. Hydroxyl free radical reactions with amino acids and proteins: Studies by electron spin resonance spectroscopy and spin-trapping. Biochim, Biophys. Acta 1984; 790: 238-50.
85. Ericson MC, Hiltin HO. Influence of histidine on lipid peroxidation in sarcoplasmic reticulum. Arch. Biochem. Biophys. 1992; 292: 427-32
86. Bretschneider HJ. Myocardial protection. Thorac. Cardiovasc. Surg. 1980; 28: 295-302.
87. Heinemeyer D, Belles G, Stapenhorst K. Intracellular pH measurement during cardiac arrest in ventricular myocardium by Bretschneider's cardioplegic solution HTK and St Thomas Hospital solution with and without procaine. Thorac, Cardiovasc Surg. 1987; 35:48-52.